Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

10.36

-0.46 (-4.25%)

At close: Aug 28, 2026, 4:00 PM EDT

10.45

+0.09 (0.87%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	598.64	737.06	392.1	195.81	102.3	164.16
Cash & Short-Term Investments	598.64	737.06	392.1	195.81	102.3	164.16
Cash Growth	53.05%	87.98%	100.25%	91.41%	-37.68%	-28.02%
Accounts Receivable	30.26	30.65	32.39	26.18	21.33	21.14
Other Receivables	-	-	0.18	-	-	-
Receivables	30.26	30.65	32.56	26.18	21.33	21.14
Inventory	3.83	3.56	3.04	2.31	1.97	1.25
Prepaid Expenses	11.7	10.86	13.28	7.79	4.03	4.75
Restricted Cash	-	-	-	0.15	-	-
Total Current Assets	644.43	782.13	440.99	232.24	129.63	191.3
Property, Plant & Equipment	25.28	24.31	15.33	18.21	17.9	11.82
Other Long-Term Assets	1.61	1.61	1.61	1.61	1.76	1.76
Total Assets	671.32	808.06	457.94	252.06	149.29	204.89

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7	4.15	4.18	4.39	5.12	4.59
Accrued Expenses	39.06	43.84	35.12	28.67	24.1	20.12
Current Portion of Leases	3.12	2.82	1.93	1.59	1.6	1.62
Current Unearned Revenue	-	-	0.13	0.26	0.58	-
Total Current Liabilities	49.17	50.81	41.35	34.9	31.4	26.34
Long-Term Debt	72.8	71.34	68.51	74.93	54.01	51.44
Long-Term Leases	3.47	2.82	5.35	6.88	8.68	5.92
Long-Term Unearned Revenue	14	14	14	14.14	13.39	13
Other Long-Term Liabilities	11.84	14.79	13.39	30.1	6.44	20.19
Total Liabilities	151.28	153.75	142.59	160.93	113.91	116.89

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	1,844	1,811	1,206	788.7	652.21	633.8
Retained Earnings	-1,324	-1,157	-891.08	-697.58	-616.84	-545.8
Shareholders' Equity	520.04	654.31	315.34	91.13	35.38	88
Total Liabilities & Equity	671.32	808.06	457.94	252.06	149.29	204.89

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	79.38	76.97	75.78	83.39	64.28	58.98
Net Cash (Debt)	519.26	660.09	316.32	112.42	38.02	105.18
Net Cash Growth	65.27%	108.68%	181.38%	195.70%	-63.86%	-37.99%
Net Cash Per Share	2.43	3.53	2.00	1.31	0.46	1.28
Filing Date Shares Outstanding	219.62	217.69	159.02	148.63	77.51	76.75
Total Common Shares Outstanding	219.59	215.93	157.75	114.96	77.2	76.73
Working Capital	595.25	731.32	399.63	197.34	98.23	164.96
Book Value Per Share	2.37	3.03	2.00	0.79	0.46	1.15
Tangible Book Value	520.04	654.31	315.34	91.13	35.38	88
Tangible Book Value Per Share	2.37	3.03	2.00	0.79	0.46	1.15
Machinery	-	21.33	18.05	16.78	13.75	12.28
Construction In Progress	-	10.26	0.12	0.28	4.07	0.58
Leasehold Improvements	-	15.28	14.53	14.7	9.07	9.07

SEC Filings: 10-K · 10-Q